Thermo Fisher Scientific to Invest $600 Million in Bioprocessing Production, Create 1,500 New Jobs

One of the top providers of scientific instrumentation, reagents and consumables, software, and services — announced March 10 that it is making a major investment to expand its bioprocessing production capabilities.

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, for its COVID-19 vaccine, which was co-developed with scientists at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID).